BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

987 related articles for article (PubMed ID: 32164470)

  • 21. Research progress of advanced microneedle drug delivery system and its application in biomedicine.
    Zhang R; Miao Q; Deng D; Wu J; Miao Y; Li Y
    Colloids Surf B Biointerfaces; 2023 Jun; 226():113302. PubMed ID: 37086686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D printing applications for transdermal drug delivery.
    Economidou SN; Lamprou DA; Douroumis D
    Int J Pharm; 2018 Jun; 544(2):415-424. PubMed ID: 29355656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
    McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hollow microneedles: A perspective in biomedical applications.
    Cárcamo-Martínez Á; Mallon B; Domínguez-Robles J; Vora LK; Anjani QK; Donnelly RF
    Int J Pharm; 2021 Apr; 599():120455. PubMed ID: 33676993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
    Lau S; Fei J; Liu H; Chen W; Liu R
    J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
    Shah V; Choudhury BK
    AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microneedles and transdermal applications.
    Sivamani RK; Liepmann D; Maibach HI
    Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
    Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
    Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo evaluation of a microneedle array device for transdermal application.
    Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
    Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity.
    Ingrole RSJ; Azizoglu E; Dul M; Birchall JC; Gill HS; Prausnitz MR
    Biomaterials; 2021 Jan; 267():120491. PubMed ID: 33217629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneedle technologies for (trans)dermal drug and vaccine delivery.
    van der Maaden K; Jiskoot W; Bouwstra J
    J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations in the use of microneedles: pain, convenience, anxiety and safety.
    Jeong HR; Lee HS; Choi IJ; Park JH
    J Drug Target; 2017 Jan; 25(1):29-40. PubMed ID: 27282644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finite element analysis and optimization of microneedle arrays for transdermal vaccine delivery: comparison of coated and dissolving microneedles.
    Yolai N; Suttirat P; Leelawattanachai J; Boonyasiriwat C; Modchang C
    Comput Methods Biomech Biomed Engin; 2023 Sep; 26(12):1379-1387. PubMed ID: 36048187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microneedles-Based Transdermal Drug Delivery Systems: A Review.
    Hao Y; Li W; Zhou X; Yang F; Qian Z
    J Biomed Nanotechnol; 2017 Dec; 13(12):1581-1597. PubMed ID: 29490749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
    Sivaraman A; Banga AK
    Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
    Yan G; Warner KS; Zhang J; Sharma S; Gale BK
    Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microneedle-mediated transdermal nanodelivery systems: a review.
    Ruan S; Zhang Y; Feng N
    Biomater Sci; 2021 Dec; 9(24):8065-8089. PubMed ID: 34752590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery.
    Peters EE; Ameri M; Wang X; Maa YF; Daddona PE
    Pharm Res; 2012 Jun; 29(6):1618-26. PubMed ID: 22258935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding the applications of microneedles in dermatology.
    Sabri AH; Ogilvie J; Abdulhamid K; Shpadaruk V; McKenna J; Segal J; Scurr DJ; Marlow M
    Eur J Pharm Biopharm; 2019 Jul; 140():121-140. PubMed ID: 31059780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.